Diastolic dysfunction with ventricular stiffening and diffuse fibrosis underpins HFpEF, with hypertension, T2D, AF, CKD, CAD, and adiposity acting as key mechanistic and management modifiers.
Background Citizens depend on high-quality healthcare; however, significant disparities in quality persist among healthcare organisations. Healthcare services are complex organisations, making it ...
Objectives Antimicrobial resistance (AMR) poses a serious threat across human, animal and environmental health. The One ...
Background Adults aged ≥65 years constitute a growing proportion of surgical oncology patients and often experience frailty, ...
Quality evidence is needed to support a new Medicare Part D medication therapy management (MTM) program performance measure, prompting a scoping review on MTM services and associated outcomes.
In August 2022 the Department of Health and Human Services (HHS) issued a notice of proposed rulemaking prohibiting covered entities, which include health care providers and health plans, from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results